URGN
UroGen Pharma (URGN)
$35
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$21.77
Daily low
$20.68
Price at open
$20.68
52 Week High
$30.00
52 Week Low
$3.42
Market cap
999.4M
Dividend yield
0.00%
Volume
751,170
Avg. volume
798,077
P/E ratio
-6.17
UroGen Pharma News
Details
Daily high
$21.77
Daily low
$20.68
Price at open
$20.68
52 Week High
$30.00
52 Week Low
$3.42
Market cap
999.4M
Dividend yield
0.00%
Volume
751,170
Avg. volume
798,077
P/E ratio
-6.17